L-base

Website

Developer of an autophagy-targeted drug intended to overcome resistance to existing anticancer drugs. The company intends to develop therapeutic agents that can overcome resistance to targeted antican...

Healthcare
Seoul, South Korea
Founded 2015
9 employees
Website

Interested in buying or selling L-base shares?

All transactions are brokered and confidential.

Valuation
$0
Share Price
N/A
Total Raised
$3.3B
Last Round
N/A
Investors
+8 other investors
View all 8 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Explore L-base's full profile

Sign up to view funding history, team members, investor details, and explore secondary market opportunities.

Free access · No credit card required